PLIVA D.D.
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 17, 2008 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 24 Total Citation Count
- Oct 19, 2001 Earliest Filing
- 12 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
- No Technology to Display
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2008/0090,847 HETEROCYCLIC COMPOUNDS AND USES THEREOF AS D-ALANYL-D-ALANINE LIGASE INHIBITORSAbandonedDec 05, 07Apr 17, 08[A61K, C07D, C12N, A61P]
7345048 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitorsExpiredJun 28, 02Mar 18, 08[A61K]
2007/0207,512 STRUCTURE-BASED DRUG DESIGN METHODS FOR IDENTIFYING D-ALA-D-ALA LIGASE INHIBITORS AS ANTIBACTERIAL DRUGSAbandonedAug 01, 06Sep 06, 07[C12Q]
2005/0171,091 Thienodibenzoazulene compounds as tumor necrosis factor inhibitorsAbandonedMar 25, 05Aug 04, 05[A61K, C07D]
2005/0054,587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseasesAbandonedFeb 10, 04Mar 10, 05[A61K]
6852702 9a-N-[N'-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin A and of 5-O-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide AExpiredAug 28, 03Feb 08, 05[A61K, C07H]
2003/0119,061 Structure-based drug design methods for identifying D-Ala-D-Ala ligase inhibitors as antibacterial drugsAbandonedJun 28, 02Jun 26, 03[G01N, G06F]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.